Dentsply Sirona declares $0.11 dividend

09:35pm, Thursday, 16'th Dec 2021 Seeking Alpha

Dentsply Sirona Declares Quarterly Cash Dividend

09:30pm, Thursday, 16'th Dec 2021 GlobeNewswire Inc.
CHARLOTTE, N.C., Dec. 16, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), announced that its Board of Directors declared a quarterly cash dividend of $0.11 pe

Dentsply Sirona Declares Quarterly Cash Dividend

09:30pm, Thursday, 16'th Dec 2021 Intrado Digital Media
CHARLOTTE, N.C., Dec. 16, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (Dentsply Sirona) (Nasdaq: XRAY), announced that its Board of Directors declared a quarterly cash dividend of $0.11 per share of common stock, an indicated annual rate of $0.44 per share. The dividend is payable on January 14, 2022 to holders of record as of December 31, 2021.

Tower Bridge Advisors Grows Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

03:32pm, Wednesday, 15'th Dec 2021 Dakota Financial News
Tower Bridge Advisors increased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.5% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 98,169 shares of the medical instruments suppliers stock after buying an additional 500 shares during the quarter. Tower Bridge Advisors holdings in []
Sumitomo Mitsui Trust Holdings Inc. trimmed its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 16.8% during the third quarter, Holdings Channel.com reports. The fund owned 1,057,691 shares of the medical instruments suppliers stock after selling 212,837 shares during the period. Sumitomo Mitsui Trust Holdings Inc.s holdings in DENTSPLY SIRONA were worth $61,399,000 at the end []
DUBLIN--(BUSINESS WIRE)--The "Dental Equipment and Maintenance Market - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com''s offering. This report analyzes the historical and present scenario of the dental equipment and maintenance market in North America to gauge its growth potential. Companies Mentioned Institut Straumann AG (Straumann Group) DENTSPLY SIRONA, Inc. A-dec, Inc. Renew Digital, LLC. Envista Holdin
Key Companies in Orthodontics Market are Institut Straumann AG (Basel, Switzerland), Dentsply Sirona (Pennsylvania, U.S.), 3M (Minnesota, U.S.), Ormco Corporation (Brea, U.S.), DB Orthodontics (Silsden, U.K.), Henry Schein, Inc. (New York U.S.), Align Technology, Inc. (San Jose, U.S.), AMERICAN ORTHODONTICS (Wisconsin, U.S.), Great Lakes Dental Technologies (Tonawanda, U.S.) Key Companies in Orthodontics Market are Institut Straumann AG (Basel, Switzerland), Dentsply Sirona (Pennsylvania, U.S.), 3M (Minnesota, U.S.), Ormco Corporation (Brea, U.S.), DB Orthodontics (Silsden, U.K.), Henry Schein, Inc. (New York U.S.), Align Technology, Inc. (San Jose, U.S.), AMERICAN ORTHODONTICS (Wisconsin, U.S.), Great Lakes Dental Technologies (Tonawanda, U.S.)
DENTSPLY SIRONA (XRAY) and 3Shape extend their partnership to simplify digitally oriented workflows for dentists and dental technicians.
Crossmark Global Holdings Inc. raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,878 shares of the medical instruments suppliers stock after acquiring an additional 243 shares during the quarter. Crossmark Global Holdings []
Dentsply Sirona is a high-quality company in the dental space with a track record of growing fundamentals. Never necessarily cheap, the current stock price presents an opportunity to add growth to you

Item 9 Labs (OTC:INLB) and DENTSPLY SIRONA (NASDAQ:XRAY) Financial Contrast

01:16pm, Saturday, 11'th Dec 2021 Dakota Financial News
Item 9 Labs (OTC:INLB) and DENTSPLY SIRONA (NASDAQ:XRAY) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends. Risk and Volatility Item 9 Labs has a beta of 1.03, suggesting that its stock []
Brokerages predict that DENTSPLY SIRONA Inc. (NASDAQ:XRAY) will announce sales of $1.13 billion for the current quarter, Zacks reports. Seven analysts have issued estimates for DENTSPLY SIRONAs earnings, with the highest sales estimate coming in at $1.16 billion and the lowest estimate coming in at $1.10 billion. DENTSPLY SIRONA posted sales of $1.08 billion in []
Chevy Chase Trust Holdings Inc. lessened its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 135,789 shares of the medical instruments suppliers stock after selling 4,926 shares during the period. Chevy Chase Trust Holdings Inc. []

Where Do Hedge Funds Stand On DENTSPLY SIRONA Inc. (XRAY)?

05:47pm, Wednesday, 08'th Dec 2021 Insider Monkey
Key Players covered in the Incontinence Care Products Market Procter & Gamble, Kimberly-Clark Corporation, PAUL HARTMANN AG, ConvaTec Inc., Wellspect HealthCare (Dentsply Sirona), Essity, Coloplast Corp, Ontex, Domtar Corporation , BD, Hollister Incorporated Key Players covered in the Incontinence Care Products Market Procter & Gamble, Kimberly-Clark Corporation, PAUL HARTMANN AG, ConvaTec Inc., Wellspect HealthCare (Dentsply Sirona), Essity, Coloplast Corp, Ontex, Domtar Corporation , BD, Hollister Incorporated
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE